Cite
MLA Citation
Tomasz Beer et al.. “Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer.” Journal for immunotherapy of cancer, vol. 3, no. 2, 2015, pp. 1–2. http://access.bl.uk/ark:/81055/vdc_100080441580.0x0000ed